US Patent Issued to Canon Medical Diagnostics on Dec. 16 for "Measurement method for fibroblast growth factor-23 by forming immunocomplexes" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,498,366, issued on Dec. 16, was assigned to Canon Medical Diagnostics Corp. (Tokyo).

"Measurement method for fibroblast growth factor-23 by forming immunocomplexes" was invented by Yuhei Yamaguchi (Shizuoka, Japan), Hiromi Miyazaki (Shizuoka, Japan) and Hitoshi Ono (Shizuoka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for measuring fibroblast growth factor-23 (hereinafter, indicated as FGF-23) in a sample, which comprises the steps of: (1) reacting in an aqueous medium, a sample and a first antibody or an antibody fragment thereof which binds to FGF-23; (2) reacting in an aqueous medium, a second antibody or an antibody fragment there...